Concepedia

Hematologic Toxicity Monitoring

Hematologic Toxicity Monitoring is a clinical assessment framework in oral chemotherapy nursing that systematically evaluates and tracks patients’ blood cell counts and related hematologic parameters to detect, manage, and mitigate treatment-induced myelosuppressive effects.

323

Publications

21K

Citations

2.3K

Authors

806

Institutions

Publications per year

2017–2026

46

Parents

Publications

323

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

, , +17

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Timothy J. Littlewood, Emilio Bajetta, J.W.R. Nortier et al. · Journal of Clinical Oncology · 2001 · 977 citations

, , +13

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

George D. Demetri, Mark G. Kris, James L. Wade et al. · Journal of Clinical Oncology · 1998 · 756 citations

, , +12

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

John A. Glaspy, Ronald Bukowski, Douglas Steinberg et al. · Journal of Clinical Oncology · 1997 · 705 citations

, , +13

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression

Karen Antman, James D. Griffin, Anthony Elias et al. · New England Journal of Medicine · 1988 · 684 citations

, , +17

1–5 of 323

Authors

2.3K

  1. JA
    John A. Glaspy

    University of California, Los Angeles, United States

    7 publications · 1.6K citations

    7

    h-index

  2. DT
    Dianne Tomita

    Amgen (United States), United States

    6 publications · 296 citations

    6

    h-index

  3. MB
    Massimo Breccia

    Sapienza University of Rome, Italy

    6 publications · 1.8K citations

    6

    h-index

  4. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    5 publications · 267 citations

    5

    h-index

  5. TL
    Tom Lillie

    Amgen (United States), United States

    4 publications · 364 citations

    4

    h-index

1–5 of 2.3K

Institutions

806

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    13 h-index

    76 publications

    4.7K citations

  2. Harvard University

    Cambridge, United States

    10 h-index

    26 publications

    8.5K citations

  3. Memorial Sloan Kettering Cancer Center

    New York, United States

    10 h-index

    34 publications

    1.7K citations

  4. Dana-Farber Cancer Institute

    Boston, United States

    9 h-index

    46 publications

    9.5K citations

  5. Duke Medical Center

    Durham, United States

    8 h-index

    31 publications

    3.2K citations

  6. Amgen (United States)

    Thousand Oaks, United States

    8 h-index

    23 publications

    962 citations

  7. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    7 h-index

    11 publications

    644 citations

  8. Stanford University

    Stanford, United States

    6 h-index

    33 publications

    2.1K citations

1–8 of 806

Venues

  1. Journal of Clinical Oncology

    30 publications · 5.7K citations

    24

    h-index

  2. PubMed

    Repository · 37 publications · 1.6K citations

    21

    h-index

  3. Cancer

    22 publications · 993 citations

    18

    h-index

  4. British Journal of Haematology

    BJH · 10 publications · 581 citations

    10

    h-index

  5. The Oncologist

    10 publications · 316 citations

    10

    h-index

1–5